Send to

Choose Destination
Arch Pathol Lab Med. 2013 Nov;137(11):1545-9. doi: 10.5858/arpa.2012-0561-CP.

A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells.

Author information

From the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Viray, Mr Li, Dr Rimm); the Biostatistics (Mr Long) and Surveys (Ms Vasalos) Departments, College of American Pathologists, Northfield, Illinois; the Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha (Dr Bridge); the Department of Pathology & Laboratory Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Jennings); the Department of Pathology, Mayo Clinic, Rochester, Minnesota (Dr Halling); and the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Dr Hameed).



The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result.


To describe a prospective, multi-institutional study to determine pathologist estimation accuracy.


Ten ×20 magnification images of hematoxylin-eosin-stained colon tissue specimens were sent as an educational component of the College of American Pathologists KRAS-B 2011 Survey. Data from 194 labs were analyzed and compared to a criterion standard with comprehensive manual nuclear counts.


Survey responses indicated low interlaboratory precision of pathologist estimation, but mean estimates were fairly accurate. A total of 5 of the 10 cases assessed showed more than 10% of respondents overestimating in a manner that could lead to false-negative test results.


The significance of estimation errors resulting in molecular testing failures with implications for patient care is unknown, but the current study suggests false-negative test results may occur.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Allen Press, Inc.
Loading ...
Support Center